LYNPARZA Trial for BRCA-Mutated HER2-Negative Breast Cancer Achieved iDFS Superiority Boundary
Source: Pixabay

LYNPARZA Trial for BRCA-Mutated HER2-Negative Breast Cancer Achieved iDFS Superiority Boundary

  In a joint statement, biopharmaceutical companies AstraZeneca and Merck & Co., Inc. ("Merck") shared that LYNPARZA (olaparib) achieved a superiority boundary in the Phase 3 OlympiA clinical trial. During…

Continue Reading LYNPARZA Trial for BRCA-Mutated HER2-Negative Breast Cancer Achieved iDFS Superiority Boundary
A Courageous Decision: The Valdez Twins Decided to Stop Cancer Before It Started
source: pixabay.com

A Courageous Decision: The Valdez Twins Decided to Stop Cancer Before It Started

  Twins Iris and Clarisa Valdez recently shared their story of courage and hope and thanked the City of Hope care team for its guidance and support. But most importantly…

Continue Reading A Courageous Decision: The Valdez Twins Decided to Stop Cancer Before It Started
Scares That Care Virtual Charity Event Supporting Marfan Syndrome Patient to Take Place August 1st
source: pixabay.com

Scares That Care Virtual Charity Event Supporting Marfan Syndrome Patient to Take Place August 1st

Scares That Care Scares That Care is a 501(c)(3) organization, first established in 2007 by Joe Ripple, dedicated to fighting the "monsters" of childhood illnesses, breast cancer, and burns. They support…

Continue Reading Scares That Care Virtual Charity Event Supporting Marfan Syndrome Patient to Take Place August 1st
A Negative Side Effect of COVID-19: Reduced Cancer Screenings
Photo by National Cancer Institute on Unsplash

A Negative Side Effect of COVID-19: Reduced Cancer Screenings

In her early 20's, Mackenzie Alleman lost her mother to breast cancer. Then, at 28, she herself underwent a preventative double mastectomy after learning that she carried the mutated BRCA1 gene.…

Continue Reading A Negative Side Effect of COVID-19: Reduced Cancer Screenings

The FDA Approves Tukysa™ for Metastatic HER2-Positive Breast Cancer

Seattle Genetics, Bothell, Washington recently issued an announcement through Drugs.com that the FDA approved Tukysa™ combined with capecitabine and trastuzumab for patients with metastatic HER2-positive breast cancer. The drug combination…

Continue Reading The FDA Approves Tukysa™ for Metastatic HER2-Positive Breast Cancer
BRCA-Mutated Breast Cancer May Negatively Impact Fertility
pandoraferrari / Pixabay

BRCA-Mutated Breast Cancer May Negatively Impact Fertility

A recent release from Yale University highlights research from Dr. Kutluk Oktay, a fertility expert, on how BRCA-mutated breast cancer may affect fertility following chemotherapy treatments. His findings suggest that women…

Continue Reading BRCA-Mutated Breast Cancer May Negatively Impact Fertility
The Halycon Machine Could Mark a Major Improvement in Radiation Treatment
source: pixabay.com

The Halycon Machine Could Mark a Major Improvement in Radiation Treatment

  The Halcyon machine holds an imaging mechanism that produces a high-quality CAT scan plus it houses a treatment unit that delivers radiation. According to a recent news release, approximately twenty-four…

Continue Reading The Halycon Machine Could Mark a Major Improvement in Radiation Treatment
A Family With the Most Significant History of Breast and Ovarian Cancer in the US
source: pixabay.com

A Family With the Most Significant History of Breast and Ovarian Cancer in the US

  Susan Winn’s family history of ovarian and breast cancer can be traced back to the 1860s. Susan’s adult daughters, Kathryn, Bridget and Maureen, were recently interviewed with CURE® (Cancer Updates Research…

Continue Reading A Family With the Most Significant History of Breast and Ovarian Cancer in the US
New Prime Editing Has The Potential to Search and Replace up to 89% of Genetic Defects
source: pixabay.com

New Prime Editing Has The Potential to Search and Replace up to 89% of Genetic Defects

  CNN recently covered a story in the publication Nature about a paper explaining base editing (or prime editing). The researchers who created the technology set forth the process of using base…

Continue Reading New Prime Editing Has The Potential to Search and Replace up to 89% of Genetic Defects

Patients in Mayo Clinic’s RIGHT Study Carried One or More Genetic Variants That May Affect Their Response to Medication

  Pharmacogenomics plays an important role in predicting whether patients will benefit from certain medications or if the medication will cause serious side effects. The process involves the way in…

Continue Reading Patients in Mayo Clinic’s RIGHT Study Carried One or More Genetic Variants That May Affect Their Response to Medication